Eli Lilly Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	72,250	65,179	45,043	34,124	28,541	28,318
Revenue Growth (YoY)	47.44%	44.70%	32.00%	19.56%	0.79%	15.40%
Cost of Revenue	12,405	11,052	8,418	7,082	6,630	7,313
Gross Profit	59,844	54,127	36,625	27,042	21,912	21,006
Selling, General & Admin	11,560	11,094	8,594	7,404	6,440	6,432
Research & Development	16,036	16,247	14,271	13,113	8,099	7,901
Other Operating Expenses	727.9	484	861	68	244.6	316.1
Total Operating Expenses	28,324	27,825	23,726	20,585	14,784	14,649
Operating Income	15,738	26,302	12,899	6,457	7,127	6,357
Interest Income	-237.7	-	-	-	-	-
Other Non-Operating Income (Expense)	82.1	-571	-219	97	-320.9	-201.6
Total Non-Operating Income (Expense)	-155.6	-571	-219	97	-320.9	-201.6
Pretax Income	31,124	25,731	12,680	6,554	6,806	6,156
Provision for Income Taxes	5,849	5,091	2,090	1,314	561.6	573.8
Net Income	25,275	20,640	10,590	5,240	6,245	5,582
Net Income to Common	25,275	20,640	10,590	5,240	6,245	5,582
Net Income Growth	127.58%	94.90%	102.10%	-16.09%	11.88%	-9.88%
Shares Outstanding (Basic)	897	897	901	900	902	907
Shares Outstanding (Diluted)	898	899	904	903	905	912
Shares Change (YoY)	-0.57%	-0.53%	0.09%	-0.15%	-0.78%	-0.09%
EPS (Basic)	28.18	23.00	11.76	5.82	6.93	6.15
EPS (Diluted)	28.15	22.95	11.71	5.80	6.90	6.12
EPS Growth	129.05%	95.99%	101.90%	-15.94%	12.75%	-9.87%
Free Cash Flow	11,823	8,972	3,760	792	5,731	6,056
Free Cash Flow Growth	31.78%	138.62%	374.75%	-86.18%	-5.36%	18.48%
Free Cash Flow Per Share	13.16	9.98	4.16	0.88	6.34	6.64
Dividends Per Share	6.230	6.000	5.200	4.520	3.920	3.400
Dividend Growth	3.83%	15.38%	15.04%	15.31%	15.29%	14.87%
Gross Margin	82.83%	83.04%	81.31%	79.25%	76.77%	74.18%
Operating Margin	21.78%	40.35%	28.64%	18.92%	24.97%	22.45%
Profit Margin	34.98%	31.67%	23.51%	15.36%	21.88%	19.71%
FCF Margin	16.36%	13.77%	8.35%	2.32%	20.08%	21.39%
EBITDA	17,781	28,299	14,666	7,984	8,650	7,905
EBITDA Margin	24.61%	43.42%	32.56%	23.40%	30.31%	27.91%
EBIT	15,738	26,302	12,899	6,457	7,127	6,357
EBIT Margin	21.78%	40.35%	28.64%	18.92%	24.97%	22.45%
Effective Tax Rate	18.79%	19.79%	16.48%	20.05%	8.25%	9.32%

SEC Filings: 10-K · 10-Q